Lupoxa Capsule contains Oxaceprol 200 mg, a therapeutic agent primarily indicated for the management of inflammatory conditions such as osteoarthritis and rheumatoid arthritis. Oxaceprol, a derivative of L-proline, exhibits anti-inflammatory and analgesic properties by modulating the inflammatory response and promoting tissue repair. The mechanism of action involves inhibition of pro-inflammatory mediators and enhancement of collagen synthesis, which contributes to the reduction of joint pain, swelling, and stiffness. Lupoxa Capsule is administered orally and is generally well-tolerated, with a favorable safety profile compared to traditional nonsteroidal anti-inflammatory drugs (NSAIDs). It is suitable for long-term use in chronic inflammatory disorders, providing symptomatic relief and improving joint function. Common adverse effects are mild and may include gastrointestinal discomfort, nausea, or skin reactions; however, serious side effects are rare. Lupoxa should be used with caution in patients with known hypersensitivity to Oxaceprol or any capsule excipients. It is recommended to follow prescribed dosages and consult healthcare professionals before initiating therapy, especially in individuals with pre-existing medical conditions or those on concurrent medications. Lupoxa Capsule represents an effective option for managing inflammation and enhancing patient quality of life in musculoskeletal disorders.